次国家级地理靶向疫苗接种规划的成本效果:系统综述
本文系统综述16项研究,覆盖霍乱、登革热、产肠毒素大肠埃希菌、甲型肝炎、日本脑炎、麻疹、轮状病毒、志贺菌和伤寒共9种疾病,所有研究均对次国家级地理靶向疫苗接种进行成本效果建模。研究普遍发现,在疾病负担异质的国家,于高负担地区实施次国家级地理靶向接种比非靶向策略更具成本效果;敏感性分析显示成本效果对疫苗价格、疫苗效力、死亡率、管理与运营成本、贴现率和治疗费用最敏感。
要点
- 在疾病负担异质的国家,高负担地区次国家级地理靶向接种比非靶向策略更具成本效果。
- 成本效果最敏感于疫苗价格、疫苗效力、死亡率、管理运营成本、贴现率和治疗费用。
- 需进一步研究支持地理靶向接种的适宜性与可行性及其作为常规免疫补充的国家情境。
核心结论
- 在疾病负担异质的国家,于高负担地区实施次国家级地理靶向疫苗接种比非靶向策略更具成本效果。
- 需进一步研究支持地理靶向接种的适宜性与可行性,并确定何种国家情境可使其成为常规免疫规划的可行补充。
研究设计与样本
- 系统综述纳入16项同行评议文献研究,覆盖霍乱、登革热、产肠毒素大肠埃希菌(ETEC)、甲型肝炎、日本脑炎、麻疹、轮状病毒、志贺菌和伤寒共9种疾病。
- 所有纳入研究均对次国家级地理靶向疫苗接种(通过常规免疫或补充免疫活动)进行成本效果建模。
主要发现
- 尽管研究设计、疾病重点和国家情境存在差异,研究普遍发现在疾病负担异质的国家,高负担地区次国家级地理靶向接种比非靶向策略更具成本效果。
- 敏感性分析显示成本效果对疫苗价格、疫苗效力、死亡率、管理与运营成本、贴现率和治疗费用的变化最敏感。
关键数值与推荐
- 系统综述识别了与地理靶向接种相关的若干关键特征,包括所采用的接种策略、建模参数的变化及其对成本效果的影响。
局限性
- 需进一步研究和支持性指导以评估地理靶向接种的适宜性与可行性,并确定何种国家情境可使其成为常规免疫规划的可行补充。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Immunization is an essential component of national health plans. However, the growing number of new vaccine introductions, vaccination campaigns and increasing administrative costs create logistic and financial challenges, especially in resource-limited settings. Sub-national geographic targeting of vaccination programs is a potential strategy for governments to reduce the impact of infectious disease outbreaks while optimizing resource allocation and reducing costs, promoting sustainability of critically important national immunization plans. We conducted a systematic review of peer-reviewed literature to identify studies that investigated the cost-effectiveness of geographically targeted sub-national vaccination programs, either through routine immunization or supplementary immunization activities. A total of 16 studies were included in our review, covering nine diseases of interest: cholera, dengue, enterotoxigenic Escherichia coli (ETEC), hepatitis A, Japanese encephalitis, measles, rotavirus, Shigella and typhoid fever. All studies modelled cost-effectiveness of geographically targeted vaccination. Despite the variation in study design, disease focus and country context, studies generally found that in countries where a heterogenous burden of disease exists, sub-national geographic targeting of vaccination programs in areas of high disease burden was more cost-effective than a non-targeted strategy. Sensitivity analysis revealed that cost-effectiveness was most sensitive to variations in vaccine price, vaccine efficacy, mortality rate, administrative and operational costs, discount rate, and treatment costs. This systematic review identified several key characteristics related to geographic targeting of vaccination, including the vaccination strategy used, variations in modelling parameters and their impact on cost-effectiveness. Additional research and guidance is needed to support the appropriateness and feasibility of geographically targeted vaccination and to determine what country context would make this a viable complement to routine immunization programs.
引用
- Getchell M, Mantaring EJ, Yee K, et al. Cost-effectiveness of sub-national geographically targeted vaccination programs: A systematic review. Vaccine. 2023. PMID: 36781333. doi:10.1016/j.vaccine.2023.02.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。